The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mesitskaia D.F.

GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Roszdrava, Moskva

Nikitina Yu.M.

GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Roszdrava, Moskva

Kopylov F.Iu.

Pervyĭ MGMU im. I.M. Sechenova, kafedra profilakticheskoĭ i neotlozhnoĭ kardiologii FPPOV, Moskva

Modern antithrombotic therapy

Authors:

Mesitskaia D.F., Nikitina Yu.M., Kopylov F.Iu.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(4): 19‑23

Read: 3005 times

Download PDF (RU)
Contact the author
Table of contents

MODERN ANTITHROMBOTIC THERAPY
MODERN ANTITHROMBOTIC THERAPY

To cite this article:

Mesitskaia DF, Nikitina YuM, Kopylov FIu. Modern antithrombotic therapy. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(4):19‑23. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Prediction and prevention of fascial dehi­scence after lapa­rotomy. Piro­gov Russian Journal of Surgery. 2025;(1):47-53
The role of endo­thelium and certain para­meters of hemo­stasis for thro­mbotic complications in endo­vascular surgery of coro­nary arte­ries. Piro­gov Russian Journal of Surgery. 2025;(6):89-97
Inno­vative approach for cardiovascular risk predicting by machine learning methods using. Russian Journal of Preventive Medi­cine. 2025;(7):36-42
Global coagulation tests in pharmacological prophylaxis of venous thro­mboembolism in patients with prostate cancer after radi­cal prostatectomy. P.A. Herzen Journal of Onco­logy. 2025;(5):41-46
Pote­ntial of global coagulation tests in dete­ction of hype­rcoagulation and thro­mbosis in onco­surgery. P.A. Herzen Journal of Onco­logy. 2025;(6):103-108
Abstract:

Keywords:

antithrombotic drugs
thrombosis
cardiovascular prophylaxis
prophylaxis of complications

Authors:

Mesitskaia D.F.

GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Roszdrava, Moskva

Nikitina Yu.M.

GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Roszdrava, Moskva

Kopylov F.Iu.

Pervyĭ MGMU im. I.M. Sechenova, kafedra profilakticheskoĭ i neotlozhnoĭ kardiologii FPPOV, Moskva

Close metadata

References:

  1. Libby P. From vulnerable plaque to vulnerable patient: a call for new definitions and risk strategies assessment. Part I. Circulation 2003; 108: 1664-1672.
  2. Gregory G.P., Bhatt D.L. The CURE trial: using clopidogrel in acute coronary syndromes without ST segment elevation. Cleveland Clin J Med 2002; 69: 377-385.
  3. Antiplatelet Trialist' Collaborative metaanalyse of randomized trials of antiplatelet therapy: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in high risk patients. Br Med J 2002; 324: 71-86.
  4. ISIS-2 (Second international Study of Infarct survival) collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
  5. Steering Committee of the Physician' Health Study Research Group. Final report of the aspirin component of the ongoing Physician' Health Study. New Engl J Med 1989; 321: 129-135.
  6. Ridker P.M., Cook N.R., Lee I.M. et al. A randomized trial of low-dose aspirin in primary prevention of cardiovascular disease in women. New Engl J Med 2005; 352: 1293-1304.
  7. Profilaktika serdechno-sosudistykh zabolevanii v klinicheskoi praktike. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012).
  8. CAPRIE Steering Committee - a randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
  9. Chen Z., Jiang L., Chen Y. et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005; 366: 1607-1621.
  10. Sabatine M.S., Cannon C.P., Gifon C.M. et al., the CLARITY-TIMI-28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST - segment elevation. New Engl J Med 2005; 352: 1179-1189.
  11. Bokeriya L.A., Alekyan B.G., Abrosimov A.V. Trombozy stentov s antiproliferativnym pokrytiem v otdalennom periode (sostoyanie problemy). Grudnaya i serdechno-sosud khir 2009; 1: 38-47.
  12. Sulimov V.A. Antitromboticheskaya terapiya pri chreskozhnykh koronarnykh vmeshatel'stvakh. Ratsion farmakoter v kardiol 2008; 3: 91-100.
  13. Lyon R., Zarins C., Lu C. et al. Vessel, plaque, and lumen morphology after transluminal balloon angioplasty. Quantitative study in distended human arteries. Arteriosclerosis 1987; 7: 3: 306-314.
  14. Stone G., Aronow H. Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy. Mayo Clin Proceed 2006; 81 (5): 641-652.
  15. Averkov O.V. "Rezistentnost'" k klopidogrelu i podkhody k ee preodoleniyu. Farmateka 2008; 7: 11-18.
  16. Mehta S., Yusuf S., Peters R. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 9281: 527-533.
  17. Steinhubl S., Charnigo R., Moliterno D. Resistance to antiplatelet resistance is it justified? J Am Coll Cardiol 2005; 42: 11: 1757-1758.
  18. Von Beckerath N., Taubert D., Pogatsa-Murray G. et al. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE Trial. Circulation 2005; 112: 19: 2946-2950.
  19. Mehta S.R., Tanguay J.F., Eikelboom J.W. et al., CURRENT-OASIS 7 trial investigators. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomized factorial trial. Lancet 2010; 376: 9748: 1233-1243.
  20. Mega J.L., Close S.L., Wiviott S.D. et al. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009; 119: 19: 2553-2560.
  21. Gurbel P.A., Bliden K.P., Butler K. et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidigrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009; 120: 25: 2577-2785.
  22. Cannon C.P., Harrington R.A., James S. et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomized double-blind study. Lancet 2010; 375: 9711: 283-293.
  23. Wallentin L., Becker R.C., Budaj A. et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 2009; 361: 11: 1045-1057.
  24. Siller-Matula J.M., Krumphuber J., Jilma B. Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol 2010; 159: 3: 502-517.
  25. Fettser D.V., Preobrazhenskii D.V., Batyraliev T.A. i dr. Blokatory glikoproteinovykh IIb/IIIa-retseptorov trombotsitov pri lechenii ostrogo koronarnogo sindroma i pri chreskozhnykh koronarnykh vmeshatel'stvakh. Ter arkh 2009; 1: 84-87.
  26. Boersma E., Harrington R.A., Moliterno D.J. et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 2002; 359: 9302: 189-198.
  27. Bershtein L.L., Saiganov S.A., Grishkin Yu.N. Standarty i perspektivy antitromboticheskoi terapii pri nestabil'noi stenokardii i infarkte miokarda bez pod''ema segmenta ST. Serdtse 2011; 5: 255-262.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.